| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,610.20
|
|
Change (%)
|
15.20 (0.95%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,590.10
-
1,655.80
|
|
52-Week Range (RS)
|
1,547.25
-
1,850.95
|
|
Beta (1 Year)
|
0.72
|
|
|
|
|
|
| Index Details |
| BSE SENSEX, BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE GREENEX, bse carbonex |
| News |
|
Corporate Details |
| Indices trade sideways; breadth positive |
| Sun Pharma gains as Q3 PAT jumps 16% YoY to Rs 3,369 cr |
| Sun Pharmaceutical Industries consolidated net profit rises 16.03% in the December 2025 quarter |
| Board of Sun Pharmaceuticals Industries recommends interim dividend |
| Sun Pharma Q3 PAT jumps 16% YoY to Rs 3,369 cr |
| Sun Pharma receives DCGI approval for generic version of semaglutide injection |
| Sun Pharmaceuticals Industries to convene board meeting |
| Sun Pharmaceutical Industries fixes record date for dividend |
| Volumes jump at Sun Pharmaceutical Industries Ltd counter |
| Sun Pharmaceutical Industries Ltd spurts 0.05%, gains for five straight sessions |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Dilip S Shanghvi |
| Ownership Group : Sun Pharma |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Res.Centre,
Tandalja,
Vadodara,
Gujarat-390020 |
Phone:91-265-6615500
Fax:91-265-2354897 |
| E-Mail : secretarial@sunpharma.com |
| URL : http://www.sunpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
27-Jan-2026 |
1639.30 |
-1.78 |
| 1Month |
01-Jan-2026 |
1720.40 |
-6.41 |
| 3Month |
03-Nov-2025 |
1707.25 |
-5.68 |
| 6Month |
01-Aug-2025 |
1629.05 |
-1.16 |
| 1Year |
01-Feb-2025 |
1742.70 |
-7.60 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Nifty 50 ETF |
1.53 |
3334.31 |
| ICICI Pru Value Fund |
4.57 |
2802.85 |
| ICICI Pru Equity & Debt Fund |
4.70 |
2332.10 |
| SBI BSE SENSEX ETF |
1.80 |
2273.26 |
| ICICI Pru Large Cap Fund |
2.61 |
2052.06 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Cipla Ltd |
1,325.85 |
0.14 |
1,672.20 |
1,283.00 |
107,099.60 |
| Dr Reddys Laboratories Ltd |
1,182.75 |
-2.93 |
1,377.95 |
1,025.90 |
98,715.91 |
| Lupin Ltd |
2,138.65 |
-0.58 |
2,228.35 |
1,774.00 |
97,729.45 |
| Zydus Lifesciences Ltd |
878.80 |
-0.72 |
1,059.00 |
797.05 |
88,427.84 |
| Mankind Pharma Ltd |
2,093.05 |
-1.50 |
2,726.75 |
2,060.00 |
86,402.17 |
|
|
|
|